Compared to normal prostate, GSK-3α and GSK-3β were up-regulated in prostate cancer with GSK-3α elevated in low Gleason tumors and GSK-3β expressed in high Gleason tumors [23]. Here, GSK3A is linked to prostate carcinoma.